Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.
Press releases published on August 18, 2025
AMS Partners with JennyCo to Combat Addiction and Reward Sobriety Through Health Tokens ($JCO)
EIN Presswire
·
August 18, 2025
JennyCo, is expanding its impact by tackling some of the most urgent health crises: mental health, addiction, and diabetes by a new collaboration with AMS. SAN DIEGO, CALIFORNIA, UNITED STATES, August 18, 2025 /EINPresswire.com/ -- JennyCo, a pioneer in …
Rezolve.ai Recognized by Everest Group as a Leading Provider of Agentic AI for HR
EIN Presswire
·
August 18, 2025
Everest Group recognized Rezolve.ai as a global leader in Agentic AI for HR, noted for autonomous support, workflow orchestration …
AppZen Partners with Sales Innovation to Accelerate Finance AI APAC Expansion
EIN Presswire
·
August 18, 2025
Partnership delivers localized go-to-market expertise across Asia-Pacific for AI agent-powered finance automation platform SAN JOSE, CA, UNITED STATES, August 18, 2025 /EINPresswire.com/ -- AppZen, the AI-first automation platform for finance, is …
Exploring the Potential of IBA101 in Combination with PD-1/PD-L1 Blockade
EIN Presswire
·
August 18, 2025
Patent Expiry and the Need for New Therapeutic Strategies Liminatus Pharma, Inc (NASDAQ:LIMN) LA PALMA, CA, UNITED STATES, August 18, 2025 /EINPresswire.com/ -- PD-1/PD-L1 inhibitors such as Keytruda, Opdivo, Tecentriq, Imfinzi, and Libtayo have been …
Liminatus Pharma Highlights Life-Saving Potential of Next-Generation Pancreatic Cancer Screening Test
EIN Presswire
·
August 18, 2025
Collaboration with Samda Biolab and INNOCS AI Targets Early Detection for Thousands of Patients Worldwide LA PALMA, CA, UNITED STATES, August 18, 2025 /EINPresswire.com/ -- Liminatus Pharma, Inc. (Nasdaq: LIMN) today reaffirmed the promising clinical …
MATAX, Inc from San Francisco, CA named Advisory Innovator of the Year by Xero’s 2025 Partner Awards
EIN Presswire
·
August 18, 2025
Accounting and bookkeeping firms recognized for delivering outstanding support to small businesses SAN FRANCISCO, CA, UNITED STATES, August 18, 2025 /EINPresswire.com/ -- MATAX, Inc has been awarded Advisory Innovator of the Year as part of Xero’s 2025 …
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 18, 2025
CAMBRIDGE, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, between August 4, 2025, and August 18, 2025, the Compensation …
Invivyd Announces Continued Neutralizing Activity of PEMGARDA® (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)
GlobeNewswire
·
August 18, 2025
New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA® (pemivibart) against XFG Centers for Disease Control data and wastewater surveillance data indicate XFG variant appears to be driving a growing wave of COVID-19 …
Eagle Pharmaceuticals Announces 2025 Annual Meeting Date
GlobeNewswire
·
August 18, 2025
WOODCLIFF LAKE, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) will be held on October 17, 2025. The …
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
GlobeNewswire
·
August 18, 2025
Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and operational expertise in the pharmaceutical and broader healthcare industry, with a …
Precision Optics to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025
GlobeNewswire
·
August 18, 2025
GARDNER, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that …
Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
GlobeNewswire
·
August 18, 2025
First T cell therapy for a solid tumor cancer and first treatment option approved in Canada for advanced melanoma after anti-PD-1 and targeted therapy SAN CARLOS, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a …
Nyxoah Reports Second Quarter Financial and Operating Results
GlobeNewswire
·
August 18, 2025
REGULATED INFORMATION Nyxoah Reports Second Quarter Financial and Operating Results FDA Approves Genio® System for U.S. Market; Company Begins Commercial Launch Mont-Saint-Guibert, Belgium – August 18, 2025, 10:10pm CET / 4:10 pm ET – Nyxoah SA (Euronext …
Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Second Trimestre 2025
GlobeNewswire
·
August 18, 2025
INFORMATIONS RÉGLEMENTÉES Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Second Trimestre 2025 La FDA approuve le système Genio® pour le marché américain ; la Société lance la commercialisation du produit Mont-Saint-Guibert, Belgique – …
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 18, 2025
BRISBANE, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory …
ORIC® Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical Officer
GlobeNewswire
·
August 18, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
Scientific Industries to Host Second Quarter Fiscal Year 2025 Financial Results Investor Call on August 20, 2025
GlobeNewswire
·
August 18, 2025
BOHEMIA, N.Y., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based pill counters, announced it will file the Form 10Q and issue a press release on August …
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
August 18, 2025
WATERTOWN, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that …
The Association of American Physicians and Surgeons Filed an Amicus Brief in the Ninth Circuit in Support of Restoring California’s Religious Exemption to Vaccination
GlobeNewswire
·
August 18, 2025
TUCSON, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (AAPS) filed its amicus brief on Friday in the U.S. Court of Appeals for the Ninth Circuit to restore in California the religious exemption to vaccination, …
HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results
GlobeNewswire
·
August 18, 2025
MIRAMAR, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by …